Health Care Organizations on Tariffs
This resource provides an in-depth look at how leading U.S. and international healthcare organizations are advocating for tariff exemptions on critical medical products. This document highlights concerns from major health industry groups, including the American Hospital Association, PhRMA, and the Association for Accessible Medicines, all of whom warn that tariffs could increase drug costs, exacerbate shortages, and disrupt healthcare supply chains. It also details international efforts by medical technology associations in Canada, Germany, and the European Union to secure exemptions that would ensure continued access to life-saving medical devices.
This document is essential for policymakers, healthcare leaders, and industry professionals seeking a comprehensive understanding of how tariffs could impact patient care and the healthcare economy. By showcasing real-world advocacy efforts, this resource underscores the urgent need for trade policies that prioritize healthcare access, affordability, and supply chain stability.